(Q39516748)

English

Standard combination versus alternating chemotherapy in small cell lung cancer: a randomised clinical trial including 394 patients. 'Petites Cellules' Group

scientific article published on August 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Standard combination versus alternating chemotherapy in small cell lung cancer: a randomised clinical trial including 394 patients. 'Petites Cellules' Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1 reference

based on heuristic

inferred from title

author name string

Urban T

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Baleyte T

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Chastang CL

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Jeannin L

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Delaval P

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Zaegel M

6

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Mornet M

7

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Coetmeur D

8

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Lebeau B

9

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

publication date

1 August 1999

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

105-113

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Chemotherapy of small cell carcinoma of the lung: Comparison of a cyclic alternative combination with simultaneous combinations of four and seven agents

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900050-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900050-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900050-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy of small-cell carcinoma of lung: a randomized comparison of alternating and sequential combination chemotherapy programs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900050-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclic alternating 'non-cross resistant' chemotherapy in the management of small cell anaplastic carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900050-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized comparison of standard chemotherapy versus alternating chemotherapy and maintenance versus no maintenance therapy for extensive-stage small-cell lung cancer: a phase III study of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900050-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. A multicenter, randomized clinical trial by the National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900050-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin-VP16 alternating with cyclophosphamide-epirubicin versus cyclophosphamide-epirubicin-vincristine in small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900050-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Canadian multicenter randomized trial comparing sequential and alternating administration of two non-cross-resistant chemotherapy combinations in patients with limited small-cell carcinoma of the lung.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900050-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized Trial of Cyclophosphamide, Doxorubicin, and Vincristine Versus Cisplatin and Etoposide Versus Alternation of These Regimens in Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900050-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900050-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors influencing use of alternating chemotherapy and radiation schedules in small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900050-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination chemotherapy of advanced lung cancer.A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900050-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy of advanced small-cell anaplastic carcinoma. Superiority of a four-drug combination to a three-drug combination

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900050-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Alternating versus sequential chemotherapy in small cell lung cancer. A randomized German multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900050-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of alternating chemotherapy and sites and extent of disease in extensive small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900050-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Subcutaneous heparin treatment increases survival in small cell lung cancer. "Petites Cellules" Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900050-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of delayed thoracic radiotherapy in complete responder patients with small-cell lung cancer. Petites Cellules Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900050-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined modality treatment of extensive small cell lung cancer: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900050-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy of small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900050-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0169-5002(99)00050-1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39516748&oldid=1833883624"